Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 30 of 30 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/24/25
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 03/01/25
End: 09/12/26
Due: 09/12/27
Phase: N/A
Priority: Normal
Start: 02/11/21
End: 07/15/21
Due: 07/15/22
Phase: N/A
Priority: Normal
Start: 04/15/18
End: 07/14/18
Due: 07/14/19
Phase: N/A
Priority: Normal
Start: 05/20/21
End: 09/06/21
Due: 09/06/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Trial of HRS-1893 in Healthy Volunteers | NCT07033455 | Atridia Pty Ltd. | user2@example.com | None | 2025-06-24 | 2025-09-30 | 2026-09-30 | - | - | 2025-07-14 |
| A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors | NCT06560138 | Atridia Pty Ltd. | user2@example.com | None | 2025-03-01 | 2026-09-12 | 2027-09-12 | - | - | 2025-07-14 |
| A Trial of SHR8735 in Healthy Subjects | NCT04701216 | Atridia Pty Ltd. | user2@example.com | None | 2021-02-11 | 2021-07-15 | 2022-07-15 | - | - | 2025-07-14 |
| A Single Dose Study of SHR0410 in Healthy Male Participants | NCT03493191 | Atridia Pty Ltd. | user2@example.com | None | 2018-04-15 | 2018-07-14 | 2019-07-14 | - | - | 2025-07-14 |
| A Trial of SHR2285 in Healthy Subjects | NCT04829305 | Atridia Pty Ltd. | user2@example.com | None | 2021-05-20 | 2021-09-06 | 2022-09-06 | - | - | 2025-07-14 |